Reproducibility of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging in Patients with Ocular
Pieter A M Janssen1,2, Teresa A Ferreira2, T H Khanh Vu3
1Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
Introduction:
Diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) can assess biological tumour characteristics of uveal melanoma (UM), the most common primary intraocular malignant tumour in adults. Recent studies propose that these techniques can aid in the differential diagnosis, provide prognostic information, and enable early assessment of treatment response following radiation therapy. However, it is important to determine the extent to which any observed differences can be attributable to true biological changes in the tumour rather than day-to-day physiological or measurement variations. Therefore, this study aimed to assess the reproducibility of ocular DWI and PWI measurements between two centres.
Method:
In this prospective study, 15 patients with UM were included. Each patient underwent two MRIs at two different centres with a mean interval of 28 days (range: 12-43 days). Apparent diffusion coefficient (ADC), relative peak intensity, and outflow percentage of the tumour were compared between the two timepoints. Mean absolute differences between the two timepoints were calculated.
Results:
Mean absolute differences between the two timepoints were 0.07 × 10-3 mm2/s (95% CI, 0.04-0.11) for ADC, 0.11 (95% CI, 0.04-0.18) for relative peak intensity, and 6 (95% CI, 3-10) percentage points for outflow percentage.
Conclusion:
This study shows that DWI and PWI parameters demonstrate reproducibility in UM patients between two different centres, with variabilities smaller than differences typically observed in differential diagnosis or treatment response assessments.
